Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Chiara Innocenti"'
Autor:
Alice Mariottini, Leonardo Marchi, Chiara Innocenti, Maria Di Cristinzi, Matteo Pasca, Stefano Filippini, Alessandro Barilaro, Claudia Mechi, Arianna Fani, Benedetta Mazzanti, Tiziana Biagioli, Francesca Materozzi, Riccardo Saccardi, Luca Massacesi, Anna Maria Repice
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
BackgroundAutologous haematopoietic stem cell transplantation (AHSCT) is highly effective in reducing new inflammatory activity in aggressive multiple sclerosis (MS). A remarkable decrease of serum neurofilament light chains (sNfL) concentration, a m
Externí odkaz:
https://doaj.org/article/4c0003b978b047bf94edb7346debe10c
Autor:
Maria Pia Sormani, Marco Capobianco, Matilde Inglese, Emanuele Angelucci, Rosanna Scimè, Raffaella Greco, Salvatore Cottone, Giancarlo Comi, Antonio Bertolotto, Alessio Signori, Riccardo Saccardi, Luca Massacesi, Lucia Moiola, Jessica Frau, Antonio Uccelli, Marco De Gobbi, Anna Maria Repice, Maria Pia Amato, Fabio Ciceri, Alice Mariottini, G. B. Zimatore, Francesca Gualandi, Gianluigi Mancardi, Giacomo Boffa, Chiara Innocenti
Publikováno v:
Neurology. 96:e1215-e1226
ObjectiveTo determine whether autologous hematopoietic stem cell transplantation (aHSCT) is able to induce durable disease remission in people with multiple sclerosis (MS), we analyzed the long-term outcomes after transplantation in a large cohort of
Autor:
Riccardo Saccardi, Anna Maria Repice, Claudia Mechi, Alice Mariottini, Arianna Fani, Stefano Filippini, Chiara Innocenti, Alessandro Barilaro, Benedetta Forci, Luca Massacesi, Giovanna Carlucci
Publikováno v:
Multiple Sclerosis Journal. 27:61-70
Background: Autologous haematopoietic stem cell transplantation (aHSCT) is a valuable option in aggressive relapsing–remitting multiple sclerosis (MS), but its efficacy in secondary progressive (SP)-MS is still controversial. Objective: Assessing e
Autor:
Alice Mariottini, Giovanni Bulgarini, Benedetta Forci, Chiara Innocenti, Fabrizia Mealli, Alessandra Mattei, Chiara Ceccarelli, Anna Maria Repice, Alessandro Barilaro, Claudia Mechi, Riccardo Saccardi, Luca Massacesi
Publikováno v:
European journal of neurology. 29(6)
Effectiveness of autologous haematopoietic stem cell transplantation (AHSCT) in relapsing-remitting multiple sclerosis (MS) is well known, but in secondary-progressive (SP)-MS it is still controversial. Therefore, AHSCT activity was evaluated in SP-M
Autor:
Ilaria Cutini, Benedetta Puccini, Alberto Fabbri, Raffaella Santi, Antonella Gozzini, Chiara Nozzoli, Riccardo Boncompagni, Chiara Innocenti, Riccardo Saccardi
Publikováno v:
Transplant Immunology. 75:101719
Autor:
A. Gozzini, Peruzzi B, Boncompagni R, Cutini I, Nozzoli C, Chiara Innocenti, A. Fani, Caporale R, Saccardi R
Publikováno v:
Annals of Hematology & Oncology. 8
Post-Transplant Lymphoproliferative Disease (PTLD) following both Solid Organ Transplantation (SOT) and Hematopoietic Stem Cell Transplantation (HSCT) is a rare life-threatening complication. The majority of PLTDs are associated to Epstein Bar Virus
Autor:
Arianna Fani, Chiara Nozzoli, Chiara Innocenti, Riccardo Saccardi, Antonella Gozzini, Ilaria Cutini, Riccardo Boncompagni
Publikováno v:
Journal of clinical immunology. 41(4)
Autor:
Anna Maria Repice, Claudia Mechi, Matteo Pasca, Luca Massacesi, Alessandro Barilaro, Giovanni Bulgarini, Benedetta Forci, Chiara Innocenti, Alice Mariottini, Riccardo Saccardi
Publikováno v:
Journal of the Neurological Sciences. 429:117751
Autor:
Alessandro Barilaro, R. Nistri, Riccardo Saccardi, Chiara Innocenti, Claudia Mechi, E. Magnani, Luca Massacesi, A. Repice, Benedetta Forci, Alice Mariottini, A. Fani
Publikováno v:
European journal of neurology. 26(4)
Background and purpose Natalizumab (NTZ) is a highly effective treatment for relapsing-remitting multiple sclerosis (MS), but its withdrawal is often followed by disease reactivation or rebound, even if other disease-modifying treatments (DMTs) are a